CD40-activated B cells as antigen-presenting cells: the final sprint toward clinical application.

Abstract

Efficient antigen presentation is a prerequisite for the development of a T-cell-mediated immune response in vitro and in vivo. CD40-activated B cells (CD40B cells) are a promising alternative to dendritic cells as professional APCs for immunotherapy. CD40 activation dramatically improves antigen presentation by normal and malignant B cells, efficiently… (More)
DOI: 10.1586/erv.13.39

Topics

1 Figure or Table

Statistics

0102030201520162017
Citations per Year

Citation Velocity: 10

Averaging 10 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.